13th Annual Pacific Psychopharmacology Conference
The University of British Columbia Division of Continuing Professional Development (UBC CPD) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide study credits for continuing medical education for physicians. This course has been reviewed and approved by the UBC Division of Continuing Professional Development. This Group Learning course meets the certification criteria of the College of Family Physicians of Canada and has been certified by UBC CPD for up to 5.75 Mainpro+ credits. This course is an Accredited Group Learning Activity eligible for up to 5.75 MOC Section 1 credits as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. Each physician should claim only those credits he/she actually spent in the activity.
Mainpro+ credits are directly transferable to the College of Pharmacists of British Columbia's Professional Development and Assessment Program (PDAP). For participants outside of BC, please check with your provincial regulating body on which Continuing Education credits are deemed acceptable.
Psychiatrists, Primary Care Physicians, Pharmacists, Psychologists, Nurses, and Social Workers
Pierre Blier, MD, PhD.
Professor, Department of Psychiatry and Cellular & Molecular Medicine, University of Ottawa; Endowed Chair in Mood Disorders Research, The Royal’s Institute of Mental Health Research (IMHR)
Daniel Mueller, MD, PhD, MHS.
Head, Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, CAMH; Professor, Department of Psychiatry, University of Toronto; Staff Psychiatrist, Mood and Anxiety Services, Toronto
Timothy Wilens, MD.
Chief, Division of Child & Adolescent Psychiatry and Co-Director, Center for Addiction Medicine, MassGeneral Hospital for Children, Boston; Director, Substance Abuse Services in Pediatric Psychopharmacology; Associate Professor of Psychiatry, Harvard Medical School
Pre & Post Conference Options
Novel Pharmacological Approaches to the Treatment of Opioid Use DisorderSep 19, 2019
At the end of this workshop participants will be able to:
- Recognize various bridging strategies to buprenorphine/naloxone
- Review injectable opioid agonist therapy
- Review newer pharmacological agents (slow release oral morphine, buprenorphine implant, extended release injectable buprenorphine, etc.)
- Evaluate patients with OUD and select appropriate therapy
Nick Mathew, MD, FRCPC, MSc, ABPN (Addiction Psychiatry), ABAM. Addiction Division Lead, Surrey Memorial Hospital; Member, Pain Medicine Residency Training Committee; Clinical Assistant Professor, Department of Psychiatry, UBC
Tamara Mihic, BScPharm, PharmD, ACPR. Clinical Pharmacy Specialist Psychiatry, St. Paul’s Hospital, Vancouver; Clinical Instructor, Faculty of Pharmaceutical Sciences, UBC
Pouya Azar, MD, FRCPC. Complex Pain and Addiction Consult Service, Vancouver General Hospital; Medical Director, St. Paul’s Hospital Inner City Youth Program Group Home
Mona Kwong, BScPharm, PharmD, MSc. Board Chair, College of Pharmacists of British Columbia; Clinical Pharmacist, Infinity Medical Specialists Clinic, Vancouver
Sharon Vipler, MD, CCFP, ABAM. Regional Division Head, Fraser Health Addiction Services; Addictions Lead, Creekside Withdrawal Management Centre, Surrey BC; Addiction Medicine Consult Team, St. Paul’s Hospital
Early bird registration: Mon. Aug 19, 2019 | Add to calendar
|By Aug 19||After Aug 19
Residents & Students*
*Proof of status required when checking in onsite.
This course incurs significant non-refundable expenses prior to the course - please read and carefully understand our cancellation policy before submitting your registration. The Division of Continuing Professional Development reserves the right to cancel a course thirty (30) days prior to the course date. Each registrant will be notified by telephone, followed by written notification and a full refund. The University of British Columbia is not responsible for any costs, including, but not limited to, airline or hotel penalties. Should you need to cancel your registration, you must do so in writing to email@example.com by Aug 30, 2019. Your registration fee, less a $50 handling charge, will be refunded. After Aug 30, 2019 no refunds will be granted for withdrawal unless a replacement can be secured by the registrant; however, the cancellation fee will still apply.